AVTX DCF Valuation - Avalo Therapeutics Inc

Dashboard Market News Investing Ideas Pricing

Watchlist Manager

Watchlist

Price: 15.95 USD -1.12% Market Closed

Market Cap: $838.4m

	Avalo Therapeutics Inc NASDAQ:AVTX	US
	Bilibili Inc NASDAQ:BILI	CN
	Shanghai Electric Group Co Ltd SSE:601727	CN
	Snap-On Inc NYSE:SNA	US
	Daehan Shipbuilding Co Ltd KRX:439260	KR
F	Fintech Ecosystem Development Corp NASDAQ:FEXD	US
	Rothschild & Co SCA PAR:ROTH	FR
	Peraso Inc NASDAQ:PRSO	US
	ON Semiconductor Corp NASDAQ:ON	US
T	Thaire Life Assurance PCL SET:THREL	TH
	Renasant Corp NYSE:RNST	US
	Petmed Express Inc NASDAQ:PETS	US
	Asia Vital Components Co Ltd TWSE:3017	TW
	Meta Financial Group Inc NASDAQ:CASH	US
	Barings BDC Inc NYSE:BBDC	US
	Marriott International Inc NASDAQ:MAR	US
	Sumitomo Electric Industries Ltd TSE:5802	JP
	BML Inc TSE:4694	JP
	Marubeni Corp TSE:8002	JP
	Grifols SA MAD:GRF	ES
	Xcel Energy Inc NASDAQ:XEL	US

AVTX's DCF value cannot be reliably calculated.

Relative Valuation Wall Street Price Targets

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.